SoloHealth has joined ATDC. Their first product, EyeSite™ is an automated self-service vision testing kiosk for use in malls and other public places. Through sophisticated optical software and an interactive video interface, users can accurately assess their distance and near vision. A printout indicates the results, provides eye health information, and refers the user to a participating eye care professional nearby.
SoloHealth is a spinout from CIBA Vision, the eye care unit of Novartis. SoloHealth founder and CEO, Bart Foster, has been working with ATDC for several years. He made his first contact with ATDC prior to the spinout from Ciba Vision and had the benefit of advice from ATDC Venture Catalyst, Lee Herron. More recently, SoloHealth completed the ATDC CapVenture program.
We are pleased to welcome Bart and the SoloHealth team to ATDC.